|
|
||||||||
| News & Events | ||||||||
|
Home / News &
Events / Safety Data Analysis and Reporting
Safety Data Analysis and Reporting: Signal Detection, Data-Mining and Next Generation Methodology for Drug Risk Assessment and Safety ResearchPresented: September 29th, 2005 Speakers: Alejandro Murua, University of Montreal and Michael O'Connell, Insightful Corporation Listen to the archived Web cast. Abstract: In its efforts to continue to serve
the public health and protect public safety, the pharmaceutical
industry is now challenged to set up sound pharmacovigilance
plans that carefully analyze and report on pre-marketing
clinical study data, minimize risk and monitor post-marketing
safety. These plans include the statistical analysis and
reporting of adverse events in clinical studies and the
proactive analysis of observational data such as FDA AERS
for signal detection and risk management. In this context,
the use of sophisticated statistical analysis models and
data mining techniques is of increasing importance in
pharmacovigilance, as these methods are able to detect
signals earlier and more accurately than current methods.
This presentation includes a review of statistical analysis,
reporting and data mining of clinical/safety data by way
of several case studies involving clinical trial and AERS
data. The case studies include statistical modeling methods
such as hierarchical Bayesian models, neural nets, tree
ensembles and logistic regression. The data analyses and
reporting examples feature the use of Presenter Information Alejandro Murua, University of Montreal
Michael O'Connell, Ph.D., Insightful Corporation
|
||||||||
| Copyright © 2000-2008 TIBCO Software Inc, All Rights Reserved | |